Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 Radiocontrast Agent Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global Radiocontrast Agent Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Radiocontrast Agent Market Performance
• 2.3 USA Radiocontrast Agent Market Performance
• 2.4 Europe Radiocontrast Agent Market Performance
• 2.5 Japan Radiocontrast Agent Market Performance
• 2.6 Korea Radiocontrast Agent Market Performance
• 2.7 India Radiocontrast Agent Market Performance
• 2.8 Southeast Asia Radiocontrast Agent Market Performance
• 2.9 South America Radiocontrast Agent Market Performance

3 Global Radiocontrast Agent Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China Radiocontrast Agent Market Performance (Volume)
• 3.3 USA Radiocontrast Agent Market Performance (Volume)
• 3.4 Europe Radiocontrast Agent Market Performance (Volume)
• 3.5 Japan Radiocontrast Agent Market Performance (Volume)
• 3.6 Korea Radiocontrast Agent Market Performance (Volume)
• 3.7 India Radiocontrast Agent Market Performance (Volume)
• 3.8 Southeast Asia Radiocontrast Agent Market Performance (Volume)
• 3.9 South America Radiocontrast Agent Market Performance (Volume)

4 Competitive Analysis

• 4.1 GE Healthcare (US)
  • 4.1.1 GE Healthcare (US) Profiles
  • 4.1.2 GE Healthcare (US) Product Information
  • 4.1.3 GE Healthcare (US) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.1.4 GE Healthcare (US) Radiocontrast Agent Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 Bracco Imaging (Italy)
  • 4.2.1 Bracco Imaging (Italy) Profiles
  • 4.2.2 Bracco Imaging (Italy) Product Information
  • 4.2.3 Bracco Imaging (Italy) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.2.4 Bracco Imaging (Italy) Radiocontrast Agent Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 Bayer HealthCare (Germany)
  • 4.3.1 Bayer HealthCare (Germany) Profiles
  • 4.3.2 Bayer HealthCare (Germany) Product Information
  • 4.3.3 Bayer HealthCare (Germany) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.3.4 Bayer HealthCare (Germany) Radiocontrast Agent Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 Guerbet (France)
  • 4.4.1 Guerbet (France) Profiles
  • 4.4.2 Guerbet (France) Product Information
  • 4.4.3 Guerbet (France) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.4.4 Guerbet (France) Radiocontrast Agent Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 Lantheus (US)
  • 4.5.1 Lantheus (US) Profiles
  • 4.5.2 Lantheus (US) Product Information
  • 4.5.3 Lantheus (US) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.5.4 Lantheus (US) Radiocontrast Agent Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 Daiichi Sankyo (Japan)
  • 4.6.1 Daiichi Sankyo (Japan) Profiles
  • 4.6.2 Daiichi Sankyo (Japan) Product Information
  • 4.6.3 Daiichi Sankyo (Japan) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.6.4 Daiichi Sankyo (Japan) Radiocontrast Agent Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 Unijules Life Sciences (India)
  • 4.7.1 Unijules Life Sciences (India) Profiles
  • 4.7.2 Unijules Life Sciences (India) Product Information
  • 4.7.3 Unijules Life Sciences (India) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.7.4 Unijules Life Sciences (India) Radiocontrast Agent Business Performance
  • 4.7.5 SWOT Analysis
• 4.8 J.B. Chemicals and Pharmaceuticals (India)
  • 4.8.1 J.B. Chemicals and Pharmaceuticals (India) Profiles
  • 4.8.2 J.B. Chemicals and Pharmaceuticals (India) Product Information
  • 4.8.3 J.B. Chemicals and Pharmaceuticals (India) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.8.4 J.B. Chemicals and Pharmaceuticals (India) Radiocontrast Agent Business Performance
  • 4.8.5 SWOT Analysis
• 4.9 Spago Nanomedicine (Sweden)
  • 4.9.1 Spago Nanomedicine (Sweden) Profiles
  • 4.9.2 Spago Nanomedicine (Sweden) Product Information
  • 4.9.3 Spago Nanomedicine (Sweden) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.9.4 Spago Nanomedicine (Sweden) Radiocontrast Agent Business Performance
  • 4.9.5 SWOT Analysis
• 4.10 Taejoon Pharm (South Korea)
  • 4.10.1 Taejoon Pharm (South Korea) Profiles
  • 4.10.2 Taejoon Pharm (South Korea) Product Information
  • 4.10.3 Taejoon Pharm (South Korea) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.10.4 Taejoon Pharm (South Korea) Radiocontrast Agent Business Performance
  • 4.10.5 SWOT Analysis
• 4.11 Jodas (India)
• 4.12 Magnus Health (India)

5 Competitive Landscape

• 5.1 Global Radiocontrast Agent Production (K Units) and Market Share by Manufacturers (2014-2019)
• 5.2 Global Radiocontrast Agent Revenue (M USD) and Market Share by Manufacturers (2014-2019)
• 5.3 Global Radiocontrast Agent Price (USD/Unit) of Manufacturers (2014-2019)
• 5.4 Global Radiocontrast Agent Gross Margin of Manufacturers (2014-2019)
• 5.5 Market Concentration

6 Global Radiocontrast Agent Market Assessment by Regions

• 6.1 Global Radiocontrast Agent Production (K Units) and Market Share by Regions (2014-2019)
• 6.2 Global Radiocontrast Agent Revenue (M USD) and Market Share by Regions (2014-2019)
• 6.3 Global Radiocontrast Agent Price (USD/Unit) by Regions (2014-2019)
• 6.4 Global Radiocontrast Agent Gross Margin by Regions (2014-2019)

7 Radiocontrast Agent Regional Analysis

• 7.1 China Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.2 USA Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.3 Europe Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.4 Japan Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.5 Korea Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.6 India Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.7 Southeast Asia Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.8 South America Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)

8 Global Radiocontrast Agent Consumption Assessment

• 8.1 Global Radiocontrast Agent Consumption and Market Share by Regions (2014-2019)
• 8.2 Global Radiocontrast Agent Consumption Value and Market Share by Regions (2014-2019)
• 8.3 Global Radiocontrast Agent Average Price (USD/Unit) by Regions (2014-2019)

9 Global Radiocontrast Agent Sales Assessment by Regions

• 9.1 Global Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.2 China Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.3 USA Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.4 Europe Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.5 Japan Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.6 Korea Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.7 India Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.8 Southeast Asia Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.9 South America Radiocontrast Agent Sales and Sales Value (2014-2019)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2020-2025

• 12.1 Production and Revenue Forecast 2020-2025
  • 12.1.1 Global Radiocontrast Agent Production and Revenue by Regions 2020-2025
  • 12.1.2 China Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.3 USA Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.4 Europe Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.5 Japan Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.6 Korea Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.7 India Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.8 Southeast Asia Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.9 South America Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
• 12.2 Sales and Sales Value Forecast 2020-2025
  • 12.2.1 Global Radiocontrast Agent Consumption and Consumption Calue by Regions 2020-2025
  • 12.2.2 Global Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.3 China Radiocontrast Agent Sales, Sales Value and Growth Rate 2020-2025
  • 12.2.4 USA Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.5 Europe Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.6 Japan Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.7 Korea Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.8 India Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.9 Southeast Asia Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.10 South America Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
• 12.3 Global Radiocontrast Agent Production and Revenue Forecast by Type 2020-2025
  • 12.3.1 Overall Market Performance
  • 12.3.2 By Type
  • 12.3.3 Barium-based Radiocontrast Agent
  • 12.3.4 Iodinated Radiocontrast Agent
  • 12.3.5 Gadolinium-based Radiocontrast Agent
  • 12.3.6 Microbubble Radiocontrast Agent
• 12.4 Global Radiocontrast Agent Sales Forecast by Application 2020-2025
  • 12.4.1 Overall Market Performance
  • 12.4.2 Radiology
  • 12.4.3 Interventional Radiology
  • 12.4.4 Interventional Cardiology
• 12.5 Global Radiocontrast Agent Price and Gross Margin Forecast
  • 13.5.1 Global Radiocontrast Agent Averages Price Development Trend Forecast 2020-2025
  • 13.5.2 Global Radiocontrast Agent Gross Margin Development Trend Forecast 2020-2025

13 Conclusion

Geographically, global Radiocontrast Agent market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
By Type
Barium-based Radiocontrast Agent
Iodinated Radiocontrast Agent
Gadolinium-based Radiocontrast Agent
Microbubble Radiocontrast Agent
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Radiocontrast Agent for each application, including
Radiology
Interventional Radiology
Interventional Cardiology
Production, consumption, revenue, market share and growth rate are the key targets for Radiocontrast Agent from 2013 to 2024 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.